Pfizer

News

Adult data back Merck & Co's challenger to Pfizer’s blockbus...

Merck & Co has built more momentum behind its attempt to depose Pfizer’s blockbuster pneumococcal conjugate vaccine Prevnar 13, with two new phase 3 trials backing its rival shot V114.<

News

Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved

Pfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at a facility in Belgium, ready for delivery if it clears phase 3 testing.

News

UK government signs contract for COVID-19 challenge trial

The UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will be deliberately infected in a controlled environment with coronavi

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer to wait until after election to file COVID-19 vaccine...

Pfizer said it will wait until after the US election to file its COVID-19 vaccine with the US regulator, as it awaits important safety data to become available.

News

Keeping up the PACE at the Scottish Medicines Consortium

Scotland backs Merck/Pfizer’s Bavencio combo for kidney canc...

The Scottish Medicines Consortium (SMC) backed NHS use of nine new medicines at its meeting this week, including Merck KGaA and Pfizer’s Bavencio as a first-line treatment for advanced kidn

News

Ibrance trial failure dashes Pfizer’s growth hopes for the d...

Pfizer already makes big revenues from its breast cancer drug Ibrance, but a late-stage trial failure has set back its hopes of even loftier sales – and set up a challenge from Eli Lilly’s

Adult data back Merck & Co's challenger to Pfizer’s blockbus...

Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved

UK government signs contract for COVID-19 challenge trial

Pfizer to wait until after election to file COVID-19 vaccine...

Scotland backs Merck/Pfizer’s Bavencio combo for kidney canc...

Ibrance trial failure dashes Pfizer’s growth hopes for the d...

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

Pfizer

Editor's Picks